Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors DW Parsons, A Roy, Y Yang, T Wang, S Scollon, K Bergstrom, ... JAMA oncology 2 (5), 616-624, 2016 | 469 | 2016 |
Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney A Roy, V Kumar, B Zorman, E Fang, KM Haines, HV Doddapaneni, ... Nature communications 6 (1), 8891, 2015 | 148 | 2015 |
Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition L Nobre, M Zapotocky, V Ramaswamy, S Ryall, J Bennett, D Alderete, ... JCO precision oncology 4, 561-571, 2020 | 116 | 2020 |
Multimodality treatment of pediatric esthesioneuroblastoma R Venkatramani, H Pan, WL Furman, JM Marron, J Haduong, ... Pediatric blood & cancer 63 (3), 465-470, 2016 | 40 | 2016 |
Systematic review of the incidence and risk factors for cerebral vasculopathy and stroke after cranial proton and photon radiation for childhood brain tumors A Bavle, A Srinivasan, F Choudhry, M Anderson, M Confer, H Simpson, ... Neuro-Oncology Practice 8 (1), 31-39, 2021 | 30 | 2021 |
Meta‐analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma A Bavle, S Tewari, A Sisson, M Chintagumpala, M Anderson, AC Paulino Pediatric blood & cancer 65 (8), e27095, 2018 | 28 | 2018 |
Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth … FY Lin, K Bergstrom, R Person, A Bavle, LY Ballester, S Scollon, ... Molecular Case Studies 2 (5), a001057, 2016 | 25 | 2016 |
Dramatic clinical and radiographic response to BRAF inhibition in a patient with progressive disseminated optic pathway glioma refractory to MEK inhibition A Bavle, J Jones, FY Lin, A Malphrus, A Adesina, J Su Pediatric Hematology and Oncology 34 (4), 254-259, 2017 | 23 | 2017 |
Encephalocraniocutaneous lipomatosis A Bavle, R Shah, N Gross, T Gavula, A Ruiz-Elizalde, K Wierenga, ... Journal of Pediatric Hematology/Oncology 40 (7), 553-554, 2018 | 18 | 2018 |
From one to many: further refinement of medulloblastoma subtypes offers promise for personalized therapy A Bavle, DW Parsons Cancer cell 31 (6), 727-729, 2017 | 18 | 2017 |
Pediatric high-grade glioma: a review of biology, prognosis, and treatment A Bavle, M Chintagumpala Journal of Radiation Oncology 7 (1), 7-15, 2018 | 11 | 2018 |
Impact of long‐term erythrocytapheresis on growth and peak height velocity of children with sickle cell disease A Bavle, A Raj, M Kong, S Bertolone Pediatric blood & cancer 61 (11), 2024-2030, 2014 | 10 | 2014 |
Reevaluating surgery and re-irradiation for locally recurrent pediatric ependymoma—a multi-institutional study DY Mak, N Laperriere, V Ramaswamy, E Bouffet, JC Murray, ... Neuro-Oncology Advances 3 (1), vdab158, 2021 | 9 | 2021 |
Cost-effectiveness and improved parent and provider satisfaction with outpatient management of pediatric oncology patients, with low-risk fever and neutropenia A Bavle, A Grimes, S Zhao, D Zinn, A Jackson, B Patel, T Porea, A Dutta, ... Journal of Pediatric Hematology/Oncology 40 (7), e415-e420, 2018 | 9 | 2018 |
Applications of genomic sequencing in pediatric CNS tumors AA Bavle, FY Lin, DW Parsons Oncology 30 (5), 411-411, 2016 | 9 | 2016 |
Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors. JAMA Oncol 2: 616–624 DW Parsons, A Roy, Y Yang, T Wang, S Scollon, K Bergstrom, ... | 4 | 2016 |
Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 (hSNF5/INI1) JEG Peterson, A Bavle, VP Mehta, RA Rauch, WE Whitehead, CA Mohila, ... Pediatric and Developmental Pathology 22 (2), 161-165, 2019 | 3 | 2019 |
NFM-08. SAFETY AND EFFICACY OF TRAMETINIB IN THE MANAGEMENT OF CHILDREN WITH RASOPATHIES A Bavle, F Choudhry, T Gavula, R Shah, A Ruiz-Elizalde, A Taylor, ... Neuro-Oncology 20 (Suppl 2), i144, 2018 | 2 | 2018 |
Outpatient management of pediatric oncology patients with low-risk fever and neutropenia: Implementation of new clinical practice guideline at Texas Children's Hospital. AA Bavle, AB Grimes, S Zhao, DJ Zinn, A Jackson, T Porea, A Dutta, ... Journal of Clinical Oncology 35 (8_suppl), 26-26, 2017 | 2 | 2017 |
Abstract IA16: Clinical genomics for children with solid tumors: Current realities and future opportunities DW Parsons, A Roy, Y Yang, T Wang, S Scollon, K Bergstrom, ... Clinical Cancer Research 22 (1_Supplement), IA16-IA16, 2016 | 2 | 2016 |